Skip to content
healthcare.dev

Etoposide

NDC 0378-3266, etoposide, capsule, from Mylan Pharmaceuticals Inc..

Product NDC
0378-3266
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075635
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-3266 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETOPOSIDE50 mg/1

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0378-3266-940037832669420 CAPSULE in 1 CARTON (0378-3266-94)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/508a418e-985f-4208-9324-2230655bb5c2
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0378-3266

Use it

Look up 0378-3266 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-3266 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-3266. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.